APC anti-mouse CD49b (pan-NK cells) Antibody
- 产品名称：
- APC anti-mouse CD49b (pan-NK cells) Antibody
- 产品类别：
- 抗体
- 产品编号：
- 108909
- 产品应用：
- 108909
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- IL-2-propagated NK1.1+ cells from C57BL/6 mice
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified with APC under optimal conditions, and is at >85% purity.
- Concentration
- 0.2 mg/ml
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.
- Excitation Laser
- Red Laser (633 nm)
- Application Notes
The DX5 clone detects cells expressing relatively high levels of CD49b and may not be useful for the detection of cells expressing low levels of CD49b. DX5 does not block NK cell killing or binding to collagen in vitro. Additional reported applications (for the relevant formats) include: complement-mediated cytotoxicity2 and immunohistochemical staining5 of formalin-fixed and paraffin-embedded tissue sections as well as immunohistochemical staining of acetone-fixed frozen sections10. The binding of DX5 antibody to splenic NK cells can be blocked by HMa2 antibody.
- Application References
(PubMed link indicates BioLegend citation) -
- Arase H, et al. 2001. J. Immunol. 167:1141. (FC)
- Sepulveda H, et al. 1999. J. Immunol. 163:1133.
- Norian LA and Allen PM. 2004. J. Immunol. 173:835. (FC)
- Andoniou CE, et al. 2005. Nature Immunology 6:1011.
- Oertelt S, et al. 2006. J. Immunol. 177:1655. (IHC) PubMed
- Bourdeau A, et al. 2007. Blood doi:10.1182/blood-2006-08-044370.
- Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
- Qui Q, et al. 2010. J. Immunol. 184:1681. (FC) PubMed
- Busche A, et al. 2011. J. Immunol. 186:2918. PubMed
- Kim HR, et al. 2011. Nephrology 16:545. (IHC) PubMed
- Seyoum B, et al. 2011. Vaccine. 29:8002. PubMed
- Younos IH, et al. 2012. Int Immunopharmacol. 13:245. PubMed
- Honjo K, et al. 2012. PNAS. PubMed.
- Huang HN, et al. 2013. Biomaterials. 34:10151. PubMed
- Product Citations
-
- Ludwik KA, et al. 2020. Cell Reports. 32(3):107931. PubMed
- Thi VAD, et al. 2019. Mol Cells. 42:869. PubMed
- Page N, et al. 2018. Immunity. 48:937. PubMed
- Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
- del Rio ML, et al. 2021. Transl Res. Online ahead of print.. PubMed
- Chen J, et al. 2022. J Nanobiotechnology. 20:283. PubMed
- Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
- Best SA, et al. 2018. Cell Metab. 27:935. PubMed
- Seyoum B, et al. 2011. Vaccine. 29:8002. PubMed
- Shan M et al. 2018. Immunity. 49(4):709-724 . PubMed
- Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
- Ho V, et al. 2016. PLoS One. 11:e0168072. PubMed
- JI B, et al. 2016. Cell Death Differ. 23:759-75. PubMed
- Ludwik KA, et al. 2021. STAR Protocols. 2(1):100270. PubMed
- Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
- Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
- LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
- Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
- Rohner L, et al. 2020. Sci Rep. 0.570833333. PubMed
- Cohen M, et al. 2010. J Immunol. 185:5869. PubMed
- Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
- Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
- Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
- Ye Y, et al. 2017. Sci Immunol. 2:17. PubMed
- Gentek R, et al. 2018. Immunity. 48:1160. PubMed
- Do-Thi VA, et al. 2021. Cancers (Basel). 13:. PubMed
- Mandour MF, et al. 2020. Infect Agent Cancer. 15:30. PubMed
- Bell CR, et al. 2022. Nat Commun. 13:2063. PubMed
- Jee JJ, et al. 2022. Nat Commun. 13:18. PubMed
- Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
- Tassi I, et al. 2014. J Immunol. 193:4303. PubMed
- Barsoumian HB, et al. 2022. Cancers (Basel). 14:. PubMed
- Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
- Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
- Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
- Jovicic N, et al. 2015. PLoS One. 10: 0134089. PubMed
- Braza MS et al. 2018. Immunity. 49(5):819-828 . PubMed
- Wang J, et al. 2020. Cell. 183(7):1867-1883.e26. PubMed
- Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
- Honjo K, et al. 2012. Proc Natl Acad Sci U S A. 109:15882. PubMed
- Younos I, et al. 2012. Int Immunopharmacol. 13:245. PubMed
- Pinto AR, et al. 2012. PLoS One. 7:e36814. PubMed
- RRID
- AB_313416 (BioLegend Cat. No. 108909) AB_313417 (BioLegend Cat. No. 108910)
- Structure
- Integrin α chain, 150 kD
- Distribution
-
NK cells, subset of T cells
- Function
- Adhesion
- Ligand/Receptor
- Collagen, laminin
- Cell Type
- NK cells, T cells
- Biology Area
- Cell Adhesion, Cell Biology, Immunology, Innate Immunity
- Molecular Family
- Adhesion Molecules, CD Molecules
- Antigen References
-
1. Arase H, et al. 2001. J. Immunol. 167:1141.
2. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
3. Sasaki K, et al. 2003. Int. Immunol. 15:701.
4. Inoue O, et al. 2003. J. Cell Biol. 160:769.
- Gene ID
- 16398 View all products for this Gene ID
- UniProt
- View information about CD49b on UniProt.org
